1. They start implementing better IR practices: conduct earnings call, go to IR conferences like all its market peers that trade at ev/ebitda multiple of 15
2. They need to improve corp governance esp any buy out proposal should consider all strategic alternatives
Market is very scared to invest in taro because of past statements by majority. even during termination of the absurd offer ever majority shareholder said "it is good for sun pharma". ever wonder how the market perceives such statements? market is scared of an unfair outcome
Most of the market don't know about the Israeli protections for minority shareholders.
Most of the market dont know about the active minority shareholders of taro
3. Don't understand why the board does not find any purpose for cash of 560m that is earning 0.5% interest. competition is acquiring left and right using debt.
4. Also, don't know why taro's products are not in many international markets